1型糖尿病患者不同部位骨折发生率分析
基于英国CPRD GOLD数据库(1987-2017),纳入6381例新治疗1型糖尿病(T1D)患者并按出生年、性别和诊所匹配6381例对照,计算骨折发生率(IR)和发生率比(IRR)。T1D患者所有骨折IRR为1.39(95%CI 1.24-1.55),腕骨、锁骨、足部、肱骨和胫腓骨骨折IRR升高,女性踝和足部骨折IRR升高,男性腕骨、锁骨和肱骨骨折IRR升高。
要点
- T1D患者所有骨折风险显著高于对照(IRR 1.39, 95%CI 1.24-1.55)。
- T1D患者腕骨、锁骨、足部、肱骨和胫腓骨骨折风险升高。
- 女性T1D踝和足部骨折风险升高,男性T1D腕骨、锁骨和肱骨骨折风险升高。
核心结论
- 新治疗T1D患者腕骨、锁骨、足部、肱骨和胫腓骨骨折发生率高于对照,其他部位无差异,升高主要见于远端骨折部位。
研究设计与样本
- 基于英国临床实践研究数据链GOLD(1987-2017)的匹配对照研究,纳入所有年龄的T1D诊断代码患者6381例,按出生年、性别和诊所匹配6381例对照。
主要发现
- T1D患者所有骨折IRR为1.39(95%CI 1.24-1.55)。
- T1D患者腕骨骨折IRR为1.41(95%CI 1.14-1.75)。
- T1D患者锁骨骨折IRR为2.10(95%CI 1.18-3.74)。
- T1D患者足部骨折IRR为1.70(95%CI 1.23-2.36)。
- T1D患者肱骨骨折IRR为1.46(95%CI 1.04-2.05),胫腓骨骨折IRR为1.67(95%CI 1.08-2.59)。
关键数值与推荐
- 女性T1D患者踝骨折IRR为2.25(95%CI 1.10-4.56),足部骨折IRR为2.11(95%CI 1.27-3.50)。
- 男性T1D患者腕骨骨折IRR为1.45(95%CI 1.14-1.86),锁骨骨折IRR为2.13(95%CI 1.13-4.02),肱骨骨折IRR为1.77(95%CI 1.10-2.83)。
临床怎么用
- 对T1D患者应关注腕骨、锁骨、足部、肱骨和胫腓骨等远端骨折部位的预防和筛查,女性重点注意踝和足部,男性重点注意腕骨、锁骨和肱骨。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Higher incidences of fractures are seen in people with type 1 diabetes (T1D), but knowledge on different fracture sites is sparse. We found a higher incidence mainly for distal fracture sites in people with T1D compared to controls. It must be further studied which fractures attributed to the higher incidence rates (IRs) at specific sites. INTRODUCTION: People with T1D have a higher incidence of fractures compared to the general population. However, sparse knowledge exists on the incidence rates of individual fracture sites. Therefore, we examined the incidence of various fracture sites in people with newly treated T1D compared to matched controls. METHODS: All people from the UK Clinical Practice Research Datalink GOLD (1987-2017), of all ages with a T1D diagnosis code (n = 6381), were included. People with T1D were matched by year of birth, sex, and practice to controls (n = 6381). Fracture IRs and incidence rate ratios (IRRs) were calculated. Analyses were stratified by fracture site and sex. RESULTS: The IR of all fractures was significantly higher in people with T1D compared to controls (IRR: 1.39 (CI95%: 1.24-1.55)). Compared to controls, the IRR for people with T1D was higher for several fracture sites including carpal (IRR: 1.41 (CI95%: 1.14-1.75)), clavicle (IRR: 2.10 (CI95%: 1.18-3.74)), foot (IRR: 1.70 (CI95%: 1.23-2.36)), humerus (IRR: 1.46 (CI95%: 1.04-2.05)), and tibia/fibula (IRR: 1.67 CI95%: 1.08-2.59)). In women with T1D, higher IRs were seen at the ankle (IRR: 2.25 (CI95%: 1.10-4.56)) and foot (IRR: 2.11 (CI95%: 1.27-3.50)), whereas in men with T1D, higher IRs were seen for carpal (IRR: 1.45 (CI95%: 1.14-1.86)), clavicle (IRR: 2.13 (CI95%: 1.13-4.02)), and humerus (IRR: 1.77 (CI95%: 1.10-2.83)) fractures. CONCLUSION: The incidence of carpal, clavicle, foot, humerus, and tibia/fibula fractures was higher in newly treated T1D, but there was no difference at other fracture sites compared to controls. Therefore, the higher incidence of fractures in newly treated people with T1D has been found mainly for distal fracture sites.
引用
- Rasmussen NH, Sarodnik C, Bours SPG, et al. The pattern of incident fractures according to fracture site in people with T1D. Osteoporos Int. 2021. PMID: 34617151. doi:10.1007/s00198-021-06175-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。